29 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 5, September/October 2014
AFRICA
223
accurate method to estimate glomerular filtration rate from serum
creatinine: A new prediction equation. Modification of diet in renal
disease study group.
Ann Int Med
1999;
130
: 461–470.
17. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural
history of congestive heart failure: The Framingham study.
New Engl J
Med
1971;
285
: 1441–1446.
18. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P,
Poole-Wilson PA,
et al
. ESC guidelines for the diagnosis and treatment
of acute and chronic heart failure 2008: The task force for the diagnosis
and treatment of acute and chronic heart failure 2008 of the European
Society of Cardiology. Developed in collaboration with the Heart
Failure Association of the ESC (HFA) and endorsed by the European
Society of Intensive Care Medicine (ESICM).
Eur J Heart Failure
2008;
10
: 933–989.
19. Ogah OS, Adebanjo AT, Otukoya AS, Jagusa TJ. Echocardiography
in Nigeria: Use, problems, reproducibility and potentials.
Cardiovasc
Ultrasound
2006;
4
: 13.
20. Devereux RB, Reichek N. Echocardiographic determination of left
ventricular mass in man. Anatomic validation of the method.
Circulation
1977;
55
: 613–618.
21. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB.
Association of carotid atherosclerosis and left ventricular hypertrophy.
J Am Coll Cardiol
1995;
25
: 83–90.
22. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle
in health and disease: Doppler echocardiography is the clinician’s rosetta
stone.
J Am Coll Cardiol
1997;
30
: 8–18.
23. Rits IA. Declaration of Helsinki. Recommendations guidings doctors in
clinical research.
World Med J
1964;
11
: 281.
24. Ogah OS, Stewart S, Falase AO, Akinyemi JO, Adegbite GD, Alabi AA,
et al
. Contemporary profile of acute heart failure in southern Nigeria:
Data from the Abeokuta heart failure clinical registry.
JAAC Heart
Failure
2014;
2
(3): 250–259.
25. Oyoo GO, Ogola EN. Clinical and socio-demographic aspects of
congestive heart failure patients at Kenyatta National Hospital, Nairobi.
East African Med J
1999;
76
: 23–27.
26. Adams KF, Jr, Uddin N, Patterson JH. Clinical predictors of in-hospital
mortality in acutely decompensated heart failure-piecing together the
outcome puzzle.
Congest Heart Failure
2008;
14
: 127–134
27. Okin PM, Roman MJ, Devereux RB, Kligfield P. Association of carotid
atherosclerosis with electrocardiographic myocardial ischemia and left
ventricular hypertrophy.
Hypertension
1996;
28
: 3–7.
28. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA,
Suresh V, Sutton GC. Incidence and aetiology of heart failure; a popu-
lation-based study.
Eur Heart J
1999;
20
: 421–428.
29. Arena R, Lavie CJ. The obesity paradox and outcome in heart failure: Is
excess bodyweight truly protective?
Future Cardiol
2010;
6
: 1–6.
30. Ballo P, Betti I, Barchielli A, Castelli G, Luca LD, Gheorghiade M,
Zuppiroli A. Body mass index, gender, and clinical outcome among
hypertensive and diabetic patients with stage a/b heart failure.
Obesity
2013;
21
(9): E500–507.
31. Komukai K, Minai K, Arase S, Ogawa T, Nakane T, Nagoshi T,
et al
.
Impact of body mass index on clinical outcome in patients hospitalized
with congestive heart failure.
Circ J
2012;
76
: 145–151.
32. Senni M, Parrella P, De Maria R, Cottini C, Bohm M, Ponikowski P,
et
al
. Predicting heart failure outcome from cardiac and comorbid condi-
tions: The 3C-HF score.
Int J Cardiol
2013;
163
: 206–211.
33. Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen
DJ, investigators. Both in- and out-hospital worsening of renal func-
tion predict outcome in patients with heart failure: Results from the
CoOrdinating study evaluating outcome of Advising and Counseling in
Heart failure (COACH).
Eur J Heart Failure
2009;
11
: 847–854.
34. Ghali JK, Wikstrand J, van Veldhuisen DJ, Fagerberg B, Goldstein S,
Hjalmarson A,
et al
, Group M-HS. The influence of renal function on
clinical outcome and response to beta-blockade in systolic heart failure:
Insights from metoprolol CR/XL randomized intervention trial in
chronic HF (MERIT-HF).
J Cardiac Failure
2009;
15
: 310–318.
35. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S,
et al.
Candesartan in heart failure: Assessment of reduction in morbid-
ity I. Renal function as a predictor of outcome in a broad spectrum of
patients with heart failure.
Circulation
2006;
113
: 671–678.
36. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left
atrial size and the risk of stroke and death. The framingham heart study.
Circulation
1995;
92
: 835–841.
37. Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran
MJ, Lewinter MM,
et al.
Heart Failure Clinical Research N.
Phosphdiesterase-5 inhibition to improve clinical status and exercise
capacity in diastolic heart failure (RELAX) trial: Rationale and design.
Circ Heart Failure
2012;
5
: 653–659.
38. Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Poole JE, Lee KL,
Bardy GH, Investigators SC-H. Outcome in African Americans and
other minorities in the Sudden Cardiac Death in HEart Failure Trial
(SCD-HEFT).
Am Heart J
2008; B: 501–506.
39. Maioli M, Bellandi F, Leoncini M, Toso A, Dabizzi RP. Randomized
Early versus Late AbciXimab in Acute Myocardial Infarction treated
with primary coronary intervention (RELAX-AMI trial).
J Am Coll
Cardiol
2007;
49
: 1517–1524.
40. Ouriel K, Castaneda F, McNamara T, Swischuk J, Tepe G, Smith JJ,
et
al
. Reteplase monotherapy and reteplase/abciximab combination ther-
apy in peripheral arterial occlusive disease: Results from the RELAX
trial.
J Vasc Interven Radiol
2004;
15
: 229–238.
41. Adlam D, Silcocks P, Sparrow N. Using BNP to develop a risk score for
heart failure in primary care.
Eur Heart J
2005;
26
: 1086–1093.